Showing results (11-20 of 81) with videos related to
Sort By:
Pageof 9
International Journal of Pediatric Obesity : IJPO : an Official Journal of the International Association for the Study of Obesity|July 5, 2011
Dietary self-monitoring and its impact on weight loss in overweight childrenDanyte S Mockus, Caroline A Macera, Deborah L Wingard, et al.Journal of Alzheimer'S Disease : JAD|February 6, 2022
Markers of Cerebrovascular Injury, Inflammation, and Plasma Lipids Are Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Cognitively Normal PersonsDeidre Jansson, Marie Wang, Ronald G Thomas, et al.Neurology|April 7, 2017
Randomized controlled trials in mild cognitive impairment: Sources of variabilityRonald C Petersen, Ronald G Thomas, Paul S Aisen, et al.Journal of Psychiatric Research|January 5, 2002
Assessing Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory: scoring and clinical implicationsMyron F Weiner, Rochelle E Tractenberg, Shelia Jin, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2013
Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approachHolly B Posner, Stefan Cano, Maria C Carrillo, et al.Journal of the International Neuropsychological Society : JINS|October 31, 2002
Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotypeKelly L Lange, Mark W Bondi, David P Salmon, et al.The Lancet. Neurology|August 5, 2008
Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective studyBrett C Meyer, Rema Raman, Thomas Hemmen, et al.Alzheimer'S & Dementia (New York, N. Y.)|September 30, 2020
Development of a novel cognitive composite outcome to assess therapeutic effects of exercise in the EXERT trial for adults with MCI: The ADAS-Cog-ExecDiane M Jacobs, Ronald G Thomas, David P Salmon, et al.Lancet (London, England)|July 22, 2008
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled studyRachelle S Doody, Svetlana I Gavrilova, Mary Sano, et al.Neuro-Degenerative Diseases|December 11, 2008
Plasma urate and progression of mild cognitive impairmentMichael C Irizarry, Rema Raman, Michael A Schwarzschild, et al.Pageof 9